Inhalation drug delivery in combating pulmonary infections: Advances and challenges
Pulmonary infections (PIs) are contributing as a significant cause of mortality across the
world. The clinical applications of a variety of therapeutics approved for PIs have been …
world. The clinical applications of a variety of therapeutics approved for PIs have been …
Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases
Lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung
cancer are prevalent worldwide, with high mortality rates. There are many pathways …
cancer are prevalent worldwide, with high mortality rates. There are many pathways …